CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 52 filers reported holding CORVUS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $11,000 | +37.5% | 2,700 | +22.7% | 0.01% | 0.0% |
| Q4 2018 | $8,000 | -61.9% | 2,200 | -10.2% | 0.01% | -28.6% |
| Q3 2018 | $21,000 | -22.2% | 2,450 | 0.0% | 0.01% | -30.0% |
| Q2 2018 | $27,000 | -3.6% | 2,450 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $28,000 | +12.0% | 2,450 | 0.0% | 0.01% | +11.1% |
| Q4 2017 | $25,000 | +2400.0% | 2,450 | +2622.2% | 0.01% | – |
| Q3 2017 | $1,000 | -94.4% | 90 | -93.9% | 0.00% | -100.0% |
| Q2 2017 | $18,000 | – | 1,482 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $8,910,000 | 1.84% |
| Novo Holdings A/S | 2,927,560 | $7,963,000 | 0.51% |
| Puissance Capital Management LP | 38,010 | $103,000 | 0.44% |
| CHI Advisors LLC | 364,132 | $990,000 | 0.39% |
| BVF INC/IL | 1,742,112 | $4,739,000 | 0.29% |
| Orbimed Advisors | 6,767,584 | $18,408,000 | 0.26% |
| EcoR1 Capital, LLC | 737,612 | $2,006,000 | 0.15% |
| Hikari Power Ltd | 60,959 | $166,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 133,700 | $364,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 1,192,742 | $3,244,000 | 0.00% |